Edition:
United States

Akers Biosciences Inc (AKR.L)

AKR.L on London Stock Exchange

112.50GBp
24 Mar 2017
Change (% chg)

0.00 (+0.00%)
Prev Close
112.50
Open
112.50
Day's High
--
Day's Low
--
Volume
16
Avg. Vol
3,048
52-wk High
255.00
52-wk Low
86.00

Latest Key Developments (Source: Significant Developments)

Akers Biosciences allowed U.S. patent for Akers Wellness tests cartridge
Thursday, 16 Feb 2017 07:00am EST 

Akers Biosciences Inc - : US patent,trademark office allowed patent covering akers bio's proprietary cartridge for optical scanning device .Akers Wellness intends to start marketing oxichek™ through direct-to-consumer channels during 2017.  Full Article

Akers Biosciences files for potential stock shelf, size not disclosed
Wednesday, 16 Nov 2016 02:37pm EST 

Akers Biosciences Inc :Files for potential stock shelf; size not disclosed - sec filing.  Full Article

Akers Biosciences reports Q3 earnings
Monday, 14 Nov 2016 07:00am EST 

Akers Biosciences Inc :Akers Biosciences announces Q3 earnings.  Full Article

Akers Biosciences settles, to sell breath technology tests
Friday, 19 Aug 2016 05:19pm EDT 

Akers Biosciences Inc : Settles dispute with Chube, Thirty Six Strategies Llc , Gavin Moran, Frank Runge - SEC Filing .Co can sell all of breath technology tests worldwide, unencumbered by past or future claims by Chube under licensing agreement.  Full Article

Akers Biosciences Q2 loss before income tax $1 million
Thursday, 11 Aug 2016 07:00am EDT 

Akers Biosciences Inc : Akers Biosciences announces h1 and q2 2016 earnings .Revenue for three months ended June 30, 2016 totaled $956,486, a 1% decrease from three months ended june 30, 2015..  Full Article

Akers Biosciences signs deal for Breathscan Oxichek(tm)
Monday, 27 Jun 2016 07:00am EDT 

Akers Biosciences Inc :Akers Biosciences signs distribution agreement for Breathscan Oxichek(tm).  Full Article

Akers Biosciences Inc announces appointment of CEO
Monday, 23 Nov 2015 02:00am EST 

Akers Biosciences Inc:Announce the appointment of John J. Gormally as Chief Executive Officer.  Full Article

Akers Biosciences Inc HIT test approved by Chinese FDA
Wednesday, 4 Nov 2015 02:00am EST 

Akers Biosciences Inc:Says China Food and Drug Administration has approved for medical use throughout Mainland China the Company's rapid tests for allergic reactions associated with the widely used blood-thinner, heparin.  Full Article

Akers Biosciences Inc signs distribution agreements
Wednesday, 30 Sep 2015 02:02am EDT 

Akers Biosciences Inc:Says that it signs distribution deals in India, Germany, Italy & Scandinavia Test for Heparin Induced Thrombocytopenia.Says it has signed distribution agreements to market its flagship test for heparin * induced thrombocytopenia (HIT) in India, Germany, Italy and Scandinavia.The Company's HIT test, based on Akers Bio's proprietary PIFA technology, is now represented in thirty countries worldwide.  Full Article

Akers Biosciences Inc signs agreement to sell METRON Breath Ketone Test Online, with key focus on amazon marketplace
Wednesday, 6 May 2015 02:00am EDT 

Akers Biosciences Inc:Has appointed InstaNatural, LLC., (Reseller) as its online marketing partner.To build consumer awareness and preference, with exclusive rights for Amazon representation, for the Company's consumer-focused METRON breath ketone test, aimed at the health and wellness market.Reseller intends to employ dedicated and specially trained personnel to promote online sales and to support the growth of the customer base.Agreement will automatically renew for one year at each anniversary, provided the Reseller achieves certain contractual milestones.  Full Article

More From Around the Web

BRIEF-Akers Biosciences allowed U.S. patent for Akers Wellness tests cartridge

* US patent,trademark office allowed patent covering akers bio's proprietary cartridge for optical scanning device